Skip to main content
. 2021 May 5;13(5):334. doi: 10.3390/toxins13050334

Table 8.

GSRS scores in the CKD group (13 S and 10 P).

T0 T2 T3 p-Value Between Time Points
GSRS 6 P 2.40 ± 0.41 2.20 ± 0.51 2.00 ± 0.32 -
S 2.38 ± 0.34 2.08 ± 0.41 1.46 ± 0.23 * 0.04
GSRS 13 P 2.20 ± 0.76 1.40 ± 0.38 1.40 ± 0.38 -
S 2.23 ± 0.27 1.15 ± 0.15 * 1.31 ± 0.20 * <0.004
Abdominal pain P 4.00 ± 0.58 4.40 ± 0.75 3.40 ± 0.25 -
S 4.85 ± 0.51 3.54 ± 0.28 * 3.62 ± 0.34 0.03 *
Constipation
syndrome
P 5.00 ± 0.69 4.00 ± 0.58 4.40 ± 0.64 -
S 6.08 ± 0.80 3.77 ± 0.41* 4.23 ± 0.71 0.02 *

Only GSRS items and domains showing statistically significant changes after the treatment (items 4, 6 and 13, abdominal pain, indigestion syndrome and constipation syndrome) are shown. * p < 0.05 vs. T0. Data are expressed as mean ± SEM, differences tested by Kruskal–Wallis multiple-comparison z-value test.